Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 537.5K | -- | 1.73% | -- | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 187.1K | -- | 0.60% | -- | 2026-06-30 |
| CITADEL ADVISORS LLC | 107.1K | -- | 0.34% | -- | 2026-06-30 |
| VANGUARD FIDUCIARY TRUST CO | 91.2K | -- | 0.29% | -- | 2026-06-30 |
| JANE STREET GROUP, LLC | 52.5K | -- | 0.17% | -- | 2026-06-30 |
| Menlo Ventures Management, L.P. | 35.7K | -- | 0.11% | -- | 2026-06-30 |
| NORTHERN TRUST CORP | 32.2K | -- | 0.10% | -- | 2026-06-30 |
| XTX Topco Ltd | 23.6K | -- | 0.08% | -- | 2026-06-30 |
| Virtu Financial LLC | 22.8K | -- | 0.07% | -- | 2026-06-30 |
| UBS Group AG | 14.4K | -- | 0.05% | -- | 2026-06-30 |
